{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:58:15Z","timestamp":1762847895705,"version":"build-2065373602"},"reference-count":32,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2025.2897","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T11:32:04Z","timestamp":1758713524000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["Multicenter validation of CEACAM6 and FOXP3 as robust prognostic biomarkers in colon cancer: Combined immunohistochemical and transcriptomic analysis"],"prefix":"10.3892","volume":"23","author":[{"given":"Yingying","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxin","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhao","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Eastern Theater Command General Hospital, Nanjing, Jiangsu 210002, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingxiao","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Jiangsu Provincial Veterans Hospital, Wuxi, Jiangsu 214000, P.R.\u00a0China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"key20251111095447_b1-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20251111095447_b2-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: A review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"key20251111095447_b3-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.annonc.2022.09.155","article-title":"The prognostic value of TILs in stage III colon cancer must consider sidedness","volume":"33","author":"Moreno","year":"2022","journal-title":"Ann Oncol"},{"issue":"17588359241287747","key":"key20251111095447_b4-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1177\/17588359241287747","article-title":"A biopsy-based immunoscore in patients with treatment-naive resectable gastric cancer","volume":"16","author":"Soeratram","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"key20251111095447_b5-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/ags3.12875","article-title":"Prognostic relevance of sarcopenia and tumor-infiltrating CD8(+) T cells in patients with hepatocellular carcinoma","volume":"9","author":"Doi","year":"2025","journal-title":"Ann Gastroenterol Surg"},{"issue":"e0325349","key":"key20251111095447_b6-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0325349","article-title":"The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance","volume":"20","author":"Kong","year":"2025","journal-title":"PLoS One"},{"issue":"225","key":"key20251111095447_b7-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03878-9","article-title":"Comprehensive analysis of single-cell and bulk RNA sequencing data unveils antigen-presenting and processing fibroblasts and establishes a predictive model in gastric cancer","volume":"25","author":"Zhang","year":"2025","journal-title":"Cancer Cell Int"},{"issue":"2008110","key":"key20251111095447_b8-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.2008110","article-title":"T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction","volume":"11","author":"Pinkert","year":"2022","journal-title":"Oncoimmunology"},{"issue":"90","key":"key20251111095447_b9-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00228-6","article-title":"Comprehensive RNA analysis of CSF reveals a role for CEACAM6 in lung cancer leptomeningeal metastases","volume":"5","author":"Li","year":"2021","journal-title":"NPJ Precis Oncol"},{"issue":"702889","key":"key20251111095447_b10-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.702889","article-title":"CEACAM gene family mutations associated with inherited breast cancer risk-A comparative oncology approach to discovery","volume":"12","author":"Huskey","year":"2021","journal-title":"Front Genet"},{"key":"key20251111095447_b11-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/sj.neo.7900201","article-title":"Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation","volume":"4","author":"Ilantzis","year":"2002","journal-title":"Neoplasia"},{"issue":"27","key":"key20251111095447_b12-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5615","article-title":"The emerging roles of CEACAM6 in human cancer (Review)","volume":"64","author":"Wu","year":"2024","journal-title":"Int J Oncol"},{"key":"key20251111095447_b13-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"51","DOI":"10.14715\/cmb\/2024.70.2.8","article-title":"Pan-cancer analysis reveals a regulatory pattern of anoikis in human cancers","volume":"70","author":"Wang","year":"2024","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"e112908","key":"key20251111095447_b14-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112908","article-title":"CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K\/AKT signaling pathway","volume":"9","author":"Zang","year":"2014","journal-title":"PLoS One"},{"issue":"e10775","key":"key20251111095447_b15-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10775","article-title":"Efficacy of bivalent CEACAM6\/4-1BBL genetic vaccine combined with anti-PD1 antibody in MC38 tumor model of mice","volume":"8","author":"Li","year":"2022","journal-title":"Heliyon"},{"key":"key20251111095447_b16-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.3892\/ol.2016.4439","article-title":"FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer","volume":"11","author":"Liu","year":"2016","journal-title":"Oncol Lett"},{"key":"key20251111095447_b17-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/his.15415","article-title":"Interobserver agreement and practice patterns for grading of colorectal carcinoma: World health organization (WHO) classification of tumours 5th edition vs. American joint committee on cancer (AJCC) 8th edition staging manual","volume":"86","author":"Karamchandani","year":"2025","journal-title":"Histopathology"},{"key":"key20251111095447_b18-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"1037","key":"key20251111095447_b19-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61061037","article-title":"Immunohistochemical assessment of maspin, \u03b2-catenin, and MMP-14 in oral potentially malignant lesions and oral squamous cell carcinoma: A retrospective observational study","volume":"61","author":"Condurache Hritcu","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"key20251111095447_b20-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"2728","key":"key20251111095447_b21-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02728","article-title":"Renal cell carcinoma (RCC) tumors display large expansion of double positive (DP) CD4+CD8+ T cells with expression of exhaustion markers","volume":"9","author":"Menard","year":"2018","journal-title":"Front Immunol"},{"issue":"15658","key":"key20251111095447_b22-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33927-5","article-title":"Clinical significance of programmed death 1 ligand-1 (CD274\/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II-III colorectal cancer","volume":"8","author":"Huang","year":"2018","journal-title":"Sci Rep"},{"key":"key20251111095447_b23-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/1055-9965.EPI-25-0287","article-title":"Density of T-cell subsets in colorectal cancer in relation to disease-specific survival","volume":"34","author":"Thomas","year":"2025","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20251111095447_b24-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41416-023-02500-x","article-title":"Stromal localization of inactive CD8(+) T cells in metastatic mismatch repair deficient colorectal cancer","volume":"130","author":"K\u00fc\u00e7\u00fckk\u00f6se","year":"2024","journal-title":"Br J Cancer"},{"issue":"151482","key":"key20251111095447_b25-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2025.151482","article-title":"The role of prostanoids in regulatory T cells and their implications in inflammatory diseases and cancers","volume":"104","author":"Prasongtanakij","year":"2025","journal-title":"Eur J Cell Biol"},{"issue":"e0321930","key":"key20251111095447_b26-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0321930","article-title":"CCR9 shapes the immune microenvironment of colorectal cancer modulating the balance between intratumoral CD8+ T cell and FoxP3+ Helios+ Treg subpopulations","volume":"20","author":"Martinez-Rios","year":"2025","journal-title":"PLoS One"},{"key":"key20251111095447_b27-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/eji.201847659","article-title":"Targeting treg cells in cancer immunotherapy","volume":"49","author":"Tanaka","year":"2019","journal-title":"Eur J Immunol"},{"key":"key20251111095447_b28-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res"},{"issue":"e14982","key":"key20251111095447_b29-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14982","article-title":"Compromised melanocyte survival due to decreased suppression of CD4(+) & CD8(+) resident memory T cells by impaired TRM-regulatory T cells in generalized vitiligo patients","volume":"33","author":"Shah","year":"2024","journal-title":"Exp Dermatol"},{"key":"key20251111095447_b30-MCO-23-6-02897","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11060-024-04766-4","article-title":"The CCL2-CCR4 axis promotes regulatory T cell trafficking to canine glioma tissues","volume":"169","author":"Panek","year":"2024","journal-title":"J Neurooncol"},{"issue":"e001496","key":"key20251111095447_b31-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001496","article-title":"SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting treg cell conversion and proliferation","volume":"9","author":"Redin","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"2192","key":"key20251111095447_b32-MCO-23-6-02897","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46167-1","article-title":"Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models","volume":"15","author":"Nakazawa","year":"2024","journal-title":"Nat Commun"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T07:54:51Z","timestamp":1762847691000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2025.2897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":32,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,9,24]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2025.2897","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"type":"print","value":"2049-9450"},{"type":"electronic","value":"2049-9469"}],"subject":[],"published":{"date-parts":[[2025,9,24]]}}}